Observational studyJCO precision oncology2024

Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer.

Petros Christopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.